These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2856702)

  • 41. Haemodynamic response to ketanserin in rabbits with Page hypertension: comparison with prazosin.
    Wright CE; Angus JA
    J Hypertens; 1983 Aug; 1(2):183-90. PubMed ID: 6681038
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cardiovascular effects of ketanserin on normotensive rats in vivo and in vitro.
    Orallo F; Rosa E; García-Ferreiro T; Campos-Toimil M; Cadavid MI; Loza MI
    Gen Pharmacol; 2000 Aug; 35(2):95-105. PubMed ID: 11707316
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chronic serotonergic blockade with ketanserin in the spontaneously hypertensive rat.
    Pettersson A; Gradin K; Hedner T; Henning M; Persson B
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S112-3. PubMed ID: 2412027
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mechanism of antihypertensive action of ketanserin in man.
    Reimann IW; Frölich JC
    Br Med J (Clin Res Ed); 1983 Aug; 287(6389):381-3. PubMed ID: 6135489
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ketanserin: a novel cardiovascular drug.
    Symoens J
    Blood Coagul Fibrinolysis; 1990 Jun; 1(2):219-24. PubMed ID: 2130934
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of ketanserin, buspirone and propranolol on arousal, pupil size and autonomic function in healthy volunteers.
    Koudas V; Nikolaou A; Hourdaki E; Giakoumaki SG; Roussos P; Bitsios P
    Psychopharmacology (Berl); 2009 Jul; 205(1):1-9. PubMed ID: 19288084
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Placental transfer and maternal and fetal hemodynamic effects of ketanserin in the pregnant ewe.
    Schneider TJ; Struijk PC; Lotgering FK; Wallenburg HC
    Eur J Obstet Gynecol Reprod Biol; 1996 Sep; 68(1-2):179-84. PubMed ID: 8886704
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Naltrexone but Not Ketanserin Antagonizes the Subjective, Cardiovascular, and Neuroendocrine Effects of Salvinorin-A in Humans.
    Maqueda AE; Valle M; Addy PH; Antonijoan RM; Puntes M; Coimbra J; Ballester MR; Garrido M; González M; Claramunt J; Barker S; Lomnicka I; Waguespack M; Johnson MW; Griffiths RR; Riba J
    Int J Neuropsychopharmacol; 2016 Jul; 19(7):. PubMed ID: 26874330
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacological manipulation of cardiovascular responses to lower body negative pressure.
    Perko G; Schmidt JF; Warberg J; Secher NH
    Eur J Appl Physiol Occup Physiol; 1996; 73(5):459-64. PubMed ID: 8803507
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cardiovascular effects of ketanserin in conscious rabbits.
    Takata M; Zhang X; Sugimoto T; Ikeda K; Tomoda F; Mikawa M; Iida H; Mizumura Y
    Jpn Heart J; 1986 Jan; 27(1):95-106. PubMed ID: 2941601
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Is there alpha-adrenergic blockade and/or serotonergic blockade during chronic ketanserin treatment?
    Ball SG; Robertson JI
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S120-2. PubMed ID: 2412031
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Is ketanserin a D receptor antagonist?
    Lancet; 1983 Mar; 1(8326 Pt 1):703-4. PubMed ID: 6132056
    [No Abstract]   [Full Text] [Related]  

  • 53. The rationale for ketanserin therapy in hypertension.
    Hansson L; Hedner T
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S39-44. PubMed ID: 2446068
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [A new antihypertensive: ketanserin].
    Salvini P
    Riv Eur Sci Med Farmacol; 1989 Feb; 11(1):77-84. PubMed ID: 2678304
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cardiovascular effects of ketanserin, a new antiserotonergic agent in the treatment of arterial hypertension.
    Ferrara LA; Fasano ML; Soro S; Rubba P; Iannuzzi A
    J Clin Pharmacol; 1985 Apr; 25(3):187-92. PubMed ID: 3158674
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of ketanserin on sodium nitroprusside requirements, arterial pressure control and heart rate following coronary artery bypass surgery.
    Hodsman NB; Colvin JR; Kenny GN
    Br J Anaesth; 1989 May; 62(5):527-31. PubMed ID: 2786422
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Does chronic ketanserin treatment enhance bradycardia in old rats by serotonergic blockade?
    Buñag RD; Davidow LW
    Aging (Milano); 1998 Apr; 10(2):102-11. PubMed ID: 9666190
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hemodynamic response to chronic ketanserin treatment in essential hypertension.
    Fagard R; Fiocchi R; Lijnen P; Staessen J; Amery A
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S128-9. PubMed ID: 2412034
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hemodynamic effects of the anti-hypertensive agent ketanserin in hypertension in man.
    Weiss YA; Fournier V; Pannier B; Laurent S; Safar ME
    Acta Cardiol; 1987; 42(5):329-37. PubMed ID: 3321806
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of short-term ketanserin treatment on the QT interval and vagal function in healthy subjects.
    Stott DJ; Robertson JI; McLenachan JM; Ball SG
    J Auton Pharmacol; 1989 Feb; 9(1):45-51. PubMed ID: 2722900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.